Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial

Ähnliche Einträge

• Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial
  Veröffentlicht: (2014)
• Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol
  von: Habl, Gregor, et al.
  Veröffentlicht: (2010)
• Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (head and neck cancer; immunochemo and radiotherapy with erbitux); a multicenter phase IV trial
  Veröffentlicht: (2013)
• Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT
  von: Jensen, Alexandra, et al.
  Veröffentlicht: (2011)
• EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer
  von: Zhou, Jiefu, et al.
  Veröffentlicht: (2025)